Study 170397-01B (Quebec)

Study for Volunteers in good health

 
 
 
 

Men

&

Women

AGE: 45 to 75 years old

BMI: 18.5 to 32.0 (inclusively)

Compensation up to:
$3,259

This study is available to menopausal or surgically sterile female volunteers.

This study involves a drug which is being developed for the treatment of patients with diseases involving muscle loss. The drug is designed to resemble a protein receptor that already exists in your body.

The goals of this study are:
1. to evaluate how safe and how well tolerated the drug is when administered subcutaneously (by injection under your skin) as a single dose and after multiple doses given 4 weeks apart in healthy subjects;
2. to evaluate how much and how quickly the drug is taken up, and eliminated by the body when administered subcutaneously;
3. to evaluate if the drug has an effect on biomarkers (molecules that indicate how your body responds to the drug) in your blood;
4. to evaluate if the drug has an effect on muscle size and strength.

Please note that there will be an extra 8 return visits to external visits in addition to the study visits.

The dates shown above and compensation amount may change. For more information, contact our recruitment department at 1 866 262-7427.

Complete an application and our staff will contact you by phone to give you an an appointment for an interview.

 

A study wih one stay and 10 return visits at the clinic.

Période 1
Admission: Tue, Mar. 20, 18 (approx. 04:00 PM)
Departure: Thu, Mar. 22, 18 (approx. 11:00 AM)
Return Blood Draw 1: Sun, Mar. 25, 18 (approx. 07:00 AM)
Return Blood Draw 2: Tue, Mar. 27, 18 (approx. 07:00 AM)
Return Blood Draw 3: Thu, Mar. 29, 18 (approx. 07:00 AM)
Return Blood Draw 4: Sun, Apr. 01, 18 (approx. 07:00 AM)
Return Blood Draw 5: Wed, Apr. 04, 18 (approx. 07:00 AM)
Return Blood Draw 6: Wed, Apr. 11, 18 (approx. 07:00 AM)
Return Blood Draw 7: Wed, Apr. 18, 18 (approx. 07:00 AM)
Return Blood Draw 8: Wed, May. 02, 18 (approx. 07:00 AM)
Return Blood Draw 9: Wed, May. 16, 18 (approx. 07:00 AM)
Return Blood Draw 10: Mon, Jun. 11, 18 (approx. 07:00 AM)

This study is available to menopausal or surgically sterile female volunteers.

This study involves a drug which is being developed for the treatment of patients with diseases involving muscle loss. The drug is designed to resemble a protein receptor that already exists in your body.

The goals of this study are:
1. to evaluate how safe and how well tolerated the drug is when administered subcutaneously (by injection under your skin) as a single dose and after multiple doses given 4 weeks apart in healthy subjects;
2. to evaluate how much and how quickly the drug is taken up, and eliminated by the body when administered subcutaneously;
3. to evaluate if the drug has an effect on biomarkers (molecules that indicate how your body responds to the drug) in your blood;
4. to evaluate if the drug has an effect on muscle size and strength.

Please note that there will be an extra 8 return visits to external visits in addition to the study visits.

The dates shown above and compensation amount may change. For more information, contact our recruitment department at 1 866 262-7427.

Complete an application and our staff will contact you by phone to give you an an appointment for an interview.

Syneos HealthTM Mailing List

Sign up for our newsletter and be among the first to receive information on any new clinical study offers. By entering your email address below, you agree to receive information emails from Syneos Health. You may also provide your mobile phone number to be informed of future studies via text messaging.

You may unsubscribe at any time.

  • If you wish to receive personalized emails, fill in the fields below.
  • Leaving so soon?

    Please tell us the main reason why you did not sign up today: